Escalon Medical Corp. Schedule 13G shows LPL Financial LLC reports shared dispositive power over 586,749 shares of Common Stock, representing 7.9% of the class. The filing states the shares are held for clients with discretionary authority; the outstanding share base cited is 7,415,329 as of February 13, 2026.
Positive
None.
Negative
None.
Insights
7.9% passive stake reported by an investment adviser.
LPL Financial LLC discloses shared dispositive authority for 586,749 shares, noting the holdings are client assets managed with discretionary authority. The filing classifies the position under Schedule 13G style disclosure, consistent with passive investment reporting.
Key dependencies include client mandate structures and potential future disclosures if the position becomes active; subsequent filings would clarify any change in intent.
Key Figures
Shares with shared dispositive power:586,749 sharesPercent of class:7.9%Shares outstanding:7,415,329 shares+1 more
4 metrics
Shares with shared dispositive power586,749 sharesreported by LPL Financial LLC
Percent of class7.9%based on outstanding shares as of Feb 13, 2026
Shares outstanding7,415,329 sharesas of February 13, 2026 (Form 10-Q cited)
Form typeSchedule 13Gpassive beneficial ownership disclosure
Key Terms
dispositive power, beneficially own, Schedule 13G
3 terms
dispositive powerregulatory
"Shared Dispositive Power 586,749.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
beneficially ownregulatory
"may be deemed to beneficially own the shares of Common Stock"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Schedule 13Gregulatory
"Item 1. Name of issuer: Escalon Medical Corp."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
What stake did LPL Financial report in Escalon Medical (ESMC)?
LPL Financial reported shared dispositive power over 586,749 shares, equal to 7.9% of common stock. The filing cites 7,415,329 shares outstanding as of February 13, 2026 as the basis for the percentage calculation.
Do the reported shares mean LPL directly owns the Escalon Medical stock?
No. The filing states LPL reports the position in its capacity as an investment adviser; the shares are held by clients who granted discretionary authority, meaning clients own the shares while LPL may direct disposition under those mandates.
What outstanding share count was used to compute the 7.9% ownership?
The percentage is calculated using 7,415,329 shares outstanding as of February 13, 2026, a figure cited from Escalon Medical's Form 10-Q for the period ended December 31, 2025, filed on February 17, 2026.
Does this Schedule 13G filing indicate active control or voting changes at Escalon Medical?
No. The Schedule 13G identifies LPL as an adviser with shared dispositive authority and reports passive beneficial ownership. The filing explicitly states clients retain rights to dividends and sale proceeds; it does not assert active control or a change in voting authority.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Escalon Medical Corp.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
296074305
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
296074305
1
Names of Reporting Persons
LPL Financial LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CALIFORNIA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
586,749.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
586,749.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.9 %
12
Type of Reporting Person (See Instructions)
BD, IA
Comment for Type of Reporting Person: Row 8 and 9. LPL Financial LLC, in its capacity as investment adviser, may be deemed to beneficially own the shares of Common Stock reported herein, which are held by clients who have granted discretionary authority to dispose of or direct the disposition of the shares to an independent contractor of LPL Financial LLC.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Escalon Medical Corp.
(b)
Address of issuer's principal executive offices:
435 Devon Park Drive, Suite 824, Wayne, PA 19087
Item 2.
(a)
Name of person filing:
LPL Financial LLC ("LPL")
(b)
Address or principal business office or, if none, residence:
4707 Executive Drive, San Diego, CA 92121.
(c)
Citizenship:
California
(d)
Title of class of securities:
Common Stock, $0.001 par value
(e)
CUSIP Number(s):
296074305
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information requested by this paragraph is incorporated herein by reference to the cover page to this Schedule 13G.
(b)
Percent of class:
The information requested by this paragraph is incorporated herein by reference to the cover page to this Schedule 13G. Percentage ownership is based on 7,415,329 shares of Common Stock outstanding as of February 13, 2026, as reported in the Issuer's Report on Form 10-Q for the period ended December 31, 2025 filed with the Securities and Exchange Commission on February 17, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information requested by this paragraph is incorporated herein by reference to the cover page to this Schedule 13G.
(ii) Shared power to vote or to direct the vote:
The information requested by this paragraph is incorporated herein by reference to the cover page to this Schedule 13G.
(iii) Sole power to dispose or to direct the disposition of:
The information requested by this paragraph is incorporated herein by reference to the cover page to this Schedule 13G.
(iv) Shared power to dispose or to direct the disposition of:
The information requested by this paragraph is incorporated herein by reference to the cover page to this Schedule 13G.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The shares of Common Stock reported herein by LPL in its capacity as investment adviser are owned by clients who have granted discretionary authority to dispose of or direct the disposition of such shares to an independent contractor of LPL. Those clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such shares. No such clients are known to have such right or power with respect to more than five percent of the Common Stock.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
